Mark Seraly, MD
Retina Specialist · Cleveland, OHNPI 1205396918
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,790 of the $2,607 with a category attached, or 68.7%. 9 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 48.3% of the total. Reporting peaked in 2023 at $1,790 and has fallen 78.4% since, to $387 in 2025. That places this record below the midpoint for retina specialist clinicians in OH, where the typical reported total is $4,390.
Across 43 payments — averaging $60.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$1K
- Regeneron Healthcare Solutions, Inc.$355
- Apellis Pharmaceuticals, Inc.$321
- Genentech USA, Inc.$178
- Coherus Oncology, Inc.$131
- Astellas Pharma US Inc$127
- plus $236 from 3 others
What the payments were for
- Travel & lodging$81731%
- Food & beverage$1,79069%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 13 | $1,260 |
| Regeneron Healthcare Solutions, Inc. | 15 | $355 |
| Apellis Pharmaceuticals, Inc. | 6 | $321 |
| Genentech USA, Inc. | 4 | $178 |
| Coherus Oncology, Inc. | 1 | $131 |
| Astellas Pharma US Inc | 1 | $127 |
| AbbVie | 1 | $109 |
| Sight Sciences, Inc. | 1 | $102 |
| Sandoz | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS ELITE$906
- Syfovre$247
- EYLEA HD$135
- Cimerli$131
- Izervay$127
- SUSVIMO$116
- XEN GLAUCOMA TREATMENT SYSTEM$109
- OMNI(R) SURGICAL SYSTEM (US)$102
How this compares
$2,607 in reported general payments places this provider in the 40th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 151 | $4,742 |
| Ofloxacin | 90 | $942 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Cleveland
- Sumit SharmaCleveland$428K
- Aleksandra RachitskayaCleveland$303K
- Katherine TalcottCleveland$272K
- Suber HuangCleveland$124K
- Ananth SastryCleveland$44K
- Phoebe LinCleveland$22K
- Warren SobolCleveland$5K
- Abhishek NaiduCleveland$3K
- Mary-Grace ReevesCleveland$2K
- Joseph ConeyBeachwood$980K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.